35 results
424B3
SHPH
Shuttle Pharmaceuticals Holdings Inc
22 Mar 24
Prospectus supplement
6:07am
. In addition, in the event the Company fails to raise a full $4,500,000 in the Rights Offering, SRO LLC agreed to a backstop commitment pursuant … ”), where he directed a new five-year $221.9 million institutional commitment for cancer center research under a new NCI-approved cancer consortium
8-K
EX-10.2
SHPH
Shuttle Pharmaceuticals Holdings Inc
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
for the Offering paid by the Company may not be increased above the amounts stated herein as follows:
Fees:
Commitment Fee. BSL shall receive a commitment fee … elect to pay the Commitment Fee in cash or in shares of its common stock (“SHPH Shares”). If the Commitment Fee is paid in SHPH Shares, the number
8-K
EX-10.1
za99001 xc
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
8-K
EX-99.1
8eijdbkm17ophg6sc3cr
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
8-K
pj5r4
13 Feb 24
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering
8:00am
8-K
EX-10.1
ug6 500qnc
5 Feb 24
Entry into a Material Definitive Agreement
4:25pm
424B3
cmi3i
24 Aug 23
Prospectus supplement
2:00pm
10-Q
runosoaqjdfcb8qr5vjo
14 Nov 22
Quarterly report
5:21pm
DRS
kwwb2tv
29 Sep 22
Draft registration statement
12:00am
8-K
po9v8
6 Sep 22
Shuttle Pharmaceuticals Announces Closing of Initial Public Offering
9:14am
424B4
rdtjg
31 Aug 22
Prospectus supplement with pricing info
6:16am
UPLOAD
j2r36uuysd
31 Aug 22
Letter from SEC
12:00am